RB.L - Reckitt Benckiser Group plc

LSE - LSE Delayed Price. Currency in GBp
6,783.00
+10.00 (+0.15%)
At close: 4:35PM BST
Stock chart is not supported by your current browser
Previous Close6,773.00
Open6,756.00
Bid6,680.00 x 20000
Ask6,886.00 x 3500
Day's Range6,749.00 - 6,821.00
52 Week Range5,255.00 - 7,457.00
Volume795,946
Avg. Volume1,597,612
Market Cap47.928B
Beta0.42
PE Ratio (TTM)7.82
EPS (TTM)867.90
Earnings DateFeb 8, 2018 - Feb 12, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6,920.59
  • Cramer: One analyst report caused spice maker McCormick's...
    CNBC Videoslast month

    Cramer: One analyst report caused spice maker McCormick's...

    Jim Cramer says spice maker McCormick's stock is finally escaping the pain brought about by a January analyst report from Deutsche Bank.

  • Should Income Investors Buy Reckitt Benckiser Group plc (LON:RB.) Before Its Ex-Dividend?
    Simply Wall St.6 days ago

    Should Income Investors Buy Reckitt Benckiser Group plc (LON:RB.) Before Its Ex-Dividend?

    On the 27 September 2018, Reckitt Benckiser Group plc (LON:RB.) will be paying shareholders an upcoming dividend amount of UK£0.70 per share. However, investors must have bought the company’s stockRead More...

  • Stock investors rediscover defensives before trade war deadlines
    Reuters9 days ago

    Stock investors rediscover defensives before trade war deadlines

    The risk of trade barriers and slowing global business activity has kept the European equity market in check this year. After over a year of neglect, fund managers began in the second quarter to pour money back into firms such as yoghurt maker Danone (DANO.PA), food giant Nestle (NESN.S), drugmakers Novartis (NOVN.S) and Roche (ROG.S), as well as tobacco giant BAT (BATS.L) and the maker of Durex condoms Reckitt Benckiser (RB.L). Morgan Stanley estimates a full-blown trade war would wipe 0.8 percentage points off global GDP growth.

  • U.S. joins lawsuits against Indivior, Reckitt over drug Suboxone
    Reuters10 days ago

    U.S. joins lawsuits against Indivior, Reckitt over drug Suboxone

    The Justice Department in filings last week in federal court in Abingdon, Virginia, said it was intervening in four separate whistleblower lawsuits related to the Britain-based companies' marketing of Suboxone and the related drug Subutex. The action came after Indivior, which was spun out of Reckitt in 2014, said last month it was in "advanced discussions" with the Justice Department to resolve an investigation dating back to 2013 related to its marketing practices.

  • Reuters10 days ago

    U.S. joins lawsuits against Indivior, Reckitt over drug Suboxone

    The U.S. Justice Department has joined several whistleblower lawsuits against Indivior Plc and Reckitt Benckiser Group PLC, alleging that the drugmakers improperly marketed the opioid addiction treatment Suboxone. The Justice Department in filings last week in federal court in Abingdon, Virginia, said it was intervening in four separate whistleblower lawsuits related to the Britain-based companies' marketing of Suboxone and the related drug Subutex. The action came after Indivior, which was spun out of Reckitt in 2014, said last month it was in "advanced discussions" with the Justice Department to resolve an investigation dating back to 2013 related to its marketing practices.

  • Reuters19 days ago

    Split concerns force Durex to recall some condoms in UK and Ireland

    Durex, owned by Reckitt Benckiser, has recalled some batches of its "Real Feel" and "Latex Free" condoms in the United Kingdom and Ireland due to concerns they may burst. "Our tests have shown that some batches which are currently on the market in UK & Ireland do not pass the requirements for burst pressure towards the end of the shelf life for the product," Durex said in a statement. Durex said only a limited number of batches were affected and that customers would be offered a full refund.

  • Reuters19 days ago

    Split concerns force Durex to recall some condoms in UK and Ireland

    Durex, owned by Reckitt Benckiser, has recalled some batches of its "Real Feel" and "Latex Free" condoms in the United Kingdom and Ireland due to concerns they may burst. "Our tests have shown that some batches which are currently on the market in UK & Ireland do not pass the requirements for burst pressure towards the end of the shelf life for the product," Durex said in a statement. Durex said only a limited number of batches were affected and that customers would be offered a full refund.

  • World's Biggest Toilet-Building Spree Is Underway in India
    Bloomberg19 days ago

    World's Biggest Toilet-Building Spree Is Underway in India

    India is on the greatest toilet-building spree in human history, and it’s a windfall for companies. Prime Minister Narendra Modi’s $20 billion “Clean India” mission aims to construct 111 million latrines in five years. Almost 80 million household toilets are estimated to have been built since Modi’s 2014 pledge to ensure universal sanitation coverage by October 2019, which will mark 150 years since the birth of independence leader Mahatma Gandhi.

  • Thomson Reuters StreetEvents21 days ago

    Edited Transcript of RB.L earnings conference call or presentation 27-Jul-18 9:00am GMT

    Half Year 2018 Reckitt Benckiser Group PLC Earnings Call

  • Reckitt rally boosts FTSE
    Reuters22 days ago

    Reckitt rally boosts FTSE

    The UK's top share index advanced on Friday and posted its third week of gains as shares in consumer giant Reckitt Benckiser jumped after results and an easing of trade tensions soothed the broader market. The blue chip FTSE 100 (.FTSE) index was up 0.5 percent at 7,701.31 points at its close, joining in a rise across the broader European equity market. Heavyweight consumer staples stock Reckitt Benckiser (RB.L) was the biggest single contributor to gains as its shares jumped more than seven percent.

  • ‘Beautiful’ Sex Rates a Higher Condom Price, Reckitt CEO Says
    Bloomberg23 days ago

    ‘Beautiful’ Sex Rates a Higher Condom Price, Reckitt CEO Says

    “A beautiful sexual experience should cost 100 pounds,” Reckitt Benckiser Group Plc Chief Executive Officer Rakesh Kapoor said in jest in a conversation about the pricing potential for Durex condoms at a media event in London. Kapoor said he tells Durex employees that the products are underpriced by a factor of 10. Durex is a brand in Reckitt Benckiser’s consumer health-care division.

  • Reckitt lifts full-year revenue target as Mead Johnson deal pays off
    Reuters23 days ago

    Reckitt lifts full-year revenue target as Mead Johnson deal pays off

    The maker of Durex condoms and Lysol disinfectant raised its annual net revenue growth expectations to between 14 to 15 percent, higher than its previous target of 13 to 14 percent. Full year like-for-like sales growth is also expected to come in at the higher end of its 2 to 3 percent range, Reckitt said, as it also signalled a recovery at its Scholl footcare brand, which has struggled for the last two years. The company said its infant and child nutrition division, the acquired Mead Johnson business, was experiencing strong growth above medium-term expectations, led by China, the world's largest market for the products.

  • The Wall Street Journal23 days ago

    [$$] European Equities Market Talk Roundup

    ’s first-half results and upgraded full-year sales guidance seem to be a “decent and reassuring set of numbers,” Jefferies says. The brokerage says like-for-like sales in the second quarter were 4% ahead of market expectations as all of the company’s new divisions reported growth. The first-half margins and EPS were also “nicely ahead” of consensus, Jefferies says.

  • The Wall Street Journal23 days ago

    [$$] European Corporate Roundup for Friday

    BP’s $10.5 billion acquisition of BHP Billiton’s shale assets to boost its U.S. business is the highlight of Friday’s corporate news.

  • Reckitt Surges as Baby Formula Strength Lifts Sales Outlook
    Bloomberg23 days ago

    Reckitt Surges as Baby Formula Strength Lifts Sales Outlook

    Reckitt Benckiser Group Plc shares surged after the company raised its full-year sales outlook on a stronger performance in its infant-formula business, especially in China. The Slough, England-based maker of Nurofen painkillers and Enfamil infant nutrition products said it expects comparable sales growth at the upper end of its previous 2 percent to 3 percent range. The company last year expanded into baby formula with a $16.6 billion takeover of Mead Johnson Nutrition Co., which Chief Executive Officer Rakesh Kapoor has said is an “inflection point” for Reckitt Benckiser.

  • Reckitt Benckiser Lifts Sales Outlook as Baby Formula Surges
    Bloomberg23 days ago

    Reckitt Benckiser Lifts Sales Outlook as Baby Formula Surges

    Reckitt Benckiser Group Plc raised its full-year sales outlook on a stronger performance in its infant formula business, especially in China. The Slough, England-based maker of Nurofen painkillers and Enfamil infant nutrition products said it expects comparable sales growth at the upper end of its previous 2 percent to 3 percent range. Reckitt Benckiser said earlier this year that it expected a return to sales growth but it has joined rivals in warning that deflationary conditions in the consumer-goods industry will curtail profitability.

  • FTSE dips as cyclicals and airlines slide
    Reuters26 days ago

    FTSE dips as cyclicals and airlines slide

    The UK's top share index fell on Monday as trade tensions weighed on cyclical stocks while results from Ryanair weighed on the broader sector. With attention also focussed on the unfolding earnings season, the blue-chip FTSE 100 index was down 0.3 percent at 7,655.79 points at the close, in line with a broadly negative European market.

  • Glaxo Opens the Door to Some Radical Surgery
    Bloomberg27 days ago

    Glaxo Opens the Door to Some Radical Surgery

    Rakesh Kapoor likes to play a long game. When it comes to consumer healthcare, the Reckitt Benckiser Group Plc boss's patience may be about to pay off. GlaxoSmithKline Plc is weighing a spin-off of its consumer healthcare arm, according to the Financial Times.

  • The Wall Street Journal2 months ago

    [$$] Health and Beauty E-commerce Site Pharmapacks Raises $32.5 Million

    Pharmapacks, an Islandia, N.Y.-based e-commerce site for health, beauty, personal care and household products, has secured $32.5 million in new funding.

  • 2 months ago

    Pharmapacks Raises $32.5 Million to Fund Expansion, Automation and Talent Acquisition

    ISLANDIA, N.Y., June 12, 2018 /PRNewswire/ -- Pharmapacks, a leading e-commerce company with a proprietary technology platform that empowers brands to reach millions of consumers with a complete and cost-effective logistics, fulfillment, marketing and sales solution, today announced it has raised $32.5 million by selling a minority stake at an undisclosed valuation. The strategic round was led by multinational CPG company RB (RB.L) with additional investments from McKesson Ventures, Sealed Air (SEE) and The Emerson Group. Pharmapacks sells both direct-to-consumer through leading online marketplaces including Amazon, Walmart.com, and eBay among others, as well as on Pharmapacks.com.

  • A Look At The Intrinsic Value Of Reckitt Benckiser Group plc (LON:RB.)
    Simply Wall St.3 months ago

    A Look At The Intrinsic Value Of Reckitt Benckiser Group plc (LON:RB.)

    Does the share price for Reckitt Benckiser Group plc (LSE:RB.) reflect it’s really worth? Today, I will calculate the stock’s intrinsic value using the discounted cash flow (DCF) method. IfRead More...

  • How Do Analysts See Reckitt Benckiser Group plc (LON:RB.) Performing In The Next Couple Of Years?
    Simply Wall St.3 months ago

    How Do Analysts See Reckitt Benckiser Group plc (LON:RB.) Performing In The Next Couple Of Years?

    In December 2017, Reckitt Benckiser Group plc (LSE:RB.) released its latest earnings announcement, which signalled that the business experienced a strong tailwind, eventuating to a high double-digit earnings growth ofRead More...